Hepatic steatosis: Correlations of body mass index, CT fat measurements, and liver density with biopsy results

Diagnostic and Interventional Radiology

Volumn 18, Issue 3, 2012, Pages 282-287

  Gaba, Ron C ^a   Grace Knuttinen, M ^a   Brodsky, Tamara R ^b   Palestrant, Sarah ^a   Omene, Benedictta O ^a   Owens, Charles A ^a   Bui, James T ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Biopsy; Body mass index; Fatty liver; X ray computed tomography

Indexed keywords

ADULT; AGED; ANTERIOR SUBCUTANEOUS FAT THICKNESS; ANTHROPOMETRIC PARAMETERS; ARTICLE; BIOPSY TECHNIQUE; BLOOD TRANSFUSION; BODY FAT DISTRIBUTION; BODY MASS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATIONAL STUDY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE CLASSIFICATION; FATTY LIVER; FEMALE; HEMATOMA; HEPATOBILIARY PARAMETERS; HUMAN; HUMAN TISSUE; INTRAABDOMINAL FAT; LIVER BIOPSY; LIVER DENSITY; MAJOR CLINICAL STUDY; MALE; OBESITY; PERCUTANEOUS BIOPSY; POSTERIOR SUBCUTANEOUS FAT THICKNESS; POSTEROLATERAL SUBCUTANEOUS FAT THICKNESS; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SUBCUTANEOUS FAT THICKNESS; SUBSCAPULAR HEMATOMA; TRANSJUGULAR BIOPSY;

ADULT; AGED; BIOPSY; BODY MASS INDEX; FATTY LIVER; FEMALE; HUMANS; LIVER; MALE; MIDDLE AGED; OBESITY; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 84861493052     PISSN: 13053825     EISSN: 13053612     Source Type: Journal    
DOI: 10.4261/1305-3825.DIR.4958-11.2     Document Type: Article

References (25)

1. Reddy JK, Rao MS. Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation. Am J Physiol Gastrointest Liver Physiol 2006; 290:852-858.
2. Okosun IS, Chandra KM, Boev A, et al. Abdominal adiposity in U.S. adults: prevalence and trends, 1960-2000. Prev Med 2004; 39:197-206.
3. Ford ES, Li C, Zhao G, Tsai J. Trends in obesity and abdominal obesity among adults in the United States from 1999-2008. Int J Obes (Lond) 2011; 35:736-743.
4. Pasumarthy L, Srour J. Nonalcoholic steatohepatitis: a review of the literature and updates in management. South Med J 2010; 103:547-550.
5. Bayard M, Holt J, Boroughs E. Nonalcoholic fatty liver disease. Am Fam Physician 2006; 73:1961-1968.
6. Bohte AE, van Werven JR, Bipat S, Stoker J. The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis. Eur Radiol 2011; 21:87-97.
7. Ducluzeau PH, Manchec-Poilblanc PM, Roullier V, et al. Distribution of abdominal adipose tissue as a predictor of hepatic steatosis assessed by MRI. Clin Radiol 2010; 65:695-700.
8. Schwenzer NF, Springer F, Schraml C, Stefan N, Machann J, Schick F. Noninvasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. J Hepatol 2009; 51:433-445.
9. World Health Organization BMI Classification. Available at http://apps. who.int/bmi/index.jsp?introPage=intro_3. html. Accessed September 19, 2010.
10. Eisner BH, Zargooshi J, Berger AD, et al. Gender differences in subcutaneous and perirenal fat distribution. Surg Radiol Anat 2010; 32:879-882.
11. Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005; 41:1313-1321.
12. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale, New Jersey: Lawrence Erlbaum Associates Inc., 1988.
13. Brown DB, Cardella JF, Sacks D, et al. Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy. J Vasc Interv Radiol 2006; 17:225-232.
14. Nguyen DM, El-Serag HB. The epidemiology of obesity. Gastroenterol Clin North Am 2010; 39:1-7.
15. Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980; 55:434-438.
16. Hamer OW, Aguirre DA, Casola G, Lavine JE, Woenckhaus M, Sirlin CB. Fatty liver: imaging patterns and pitfalls. Radiographics 2006; 26:1637-1653.
17. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002; 346:1221-1231.
18. Mammen T, Keshava SN, Eapen CE, et al. Transjugular liver biopsy: a retrospective analysis of 601 cases. J Vasc Interv Radiol 2008; 19:351-358.
19. Gupta S, Wallace MJ, Cardella JF, Kundu S, Miller DL, Rose SC. Quality improvement guidelines for percutaneous needle biopsy. J Vasc Interv Radiol 2010; 21:969-975.
20. Saadeh S, Younossi ZM, Remer EM, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002; 123:745-750.
21. Talwalkar JA, Yin M, Fidler JL, Sanderson SO, Kamath PS, Ehman RL. Magnetic resonance imaging of hepatic fibrosis: emerging clinical applications. Hepatology 2008; 47:332-342.
22. Ishibashi E, Eguchi Y, Eguchi T, et al. Waist circumference correlates with hepatic fat accumulation in male Japanese patients with non-alcoholic fatty liver disease, but not in females. J Gastroenterol Hepatol 2008; 23:908-913.
23. Friedl KE. Can you be large, not obese? The distinction between body weight, body fat, abdominal fat in occupational standards. Diabetes Technol Ther 2004; 6:732-749.
24. Hamdy O, Porramatikul S, Al-Ozairi E. Metabolic obesity: the paradox between visceral and subcutaneous fat. Curr Diabetes Rev 2006; 2:367-373.
25. Akhan O, Akpinar E, Oto A, et al. Unusual imaging findings in Wilson's disease. Eur Radiol 2002; 12:66-69.